HKD 20.5
(-3.76%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -334.62 Million USD | 30.58% |
2022 | -481.99 Million USD | 30.39% |
2021 | -692.44 Million USD | -132.24% |
2020 | -298.16 Million USD | -62.6% |
2019 | -183.36 Million USD | -31.85% |
2018 | -139.07 Million USD | -176.03% |
2017 | -50.38 Million USD | -34.31% |
2016 | -37.51 Million USD | -108.15% |
2015 | -18.02 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -80.27 Million USD | -50.13% |
2024 Q1 | -53.47 Million USD | 43.97% |
2023 Q3 | -69.15 Million USD | 42.8% |
2023 Q2 | -120.89 Million USD | -603.0% |
2023 FY | -334.62 Million USD | 30.58% |
2023 Q1 | -17.19 Million USD | 34.48% |
2023 Q4 | -95.42 Million USD | -38.0% |
2022 Q1 | -84.8 Million USD | 59.97% |
2022 FY | -481.99 Million USD | 30.39% |
2022 Q4 | -26.24 Million USD | 86.46% |
2022 Q3 | -193.79 Million USD | -9.4% |
2022 Q2 | -177.15 Million USD | -108.9% |
2021 FY | -692.44 Million USD | -132.24% |
2021 Q2 | -163.32 Million USD | 29.88% |
2021 Q3 | -96.41 Million USD | 40.97% |
2021 Q4 | -211.82 Million USD | -119.71% |
2021 Q1 | -232.91 Million USD | -204.27% |
2020 Q2 | -80.62 Million USD | -68.02% |
2020 Q3 | -63.74 Million USD | 20.95% |
2020 FY | -298.16 Million USD | -62.6% |
2020 Q4 | -76.54 Million USD | -20.09% |
2020 Q1 | -47.98 Million USD | -3.35% |
2019 Q2 | -41.63 Million USD | 0.0% |
2019 FY | -183.36 Million USD | -31.85% |
2019 Q4 | -46.43 Million USD | 28.97% |
2019 Q3 | -65.36 Million USD | -56.99% |
2019 Q1 | -41.63 Million USD | 34.28% |
2018 Q1 | -20.74 Million USD | -59.8% |
2018 Q2 | -20.74 Million USD | 0.0% |
2018 Q3 | -34.22 Million USD | -64.99% |
2018 Q4 | -63.35 Million USD | -85.11% |
2018 FY | -139.07 Million USD | -176.03% |
2017 FY | -50.38 Million USD | -34.31% |
2017 Q1 | -12.2 Million USD | 4.9% |
2017 Q2 | -12.2 Million USD | 0.0% |
2017 Q3 | -12.98 Million USD | -6.33% |
2017 Q4 | -12.98 Million USD | 0.0% |
2016 Q4 | -12.83 Million USD | -0.0% |
2016 Q3 | -12.83 Million USD | -116.96% |
2016 Q1 | -5.91 Million USD | 0.0% |
2016 Q2 | -5.91 Million USD | 0.0% |
2016 FY | -37.51 Million USD | -108.15% |
2015 FY | -18.02 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 572.12% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 2039.826% |